Genomic and Targeted Proteomics Report

Understanding genomic alterations and protein expression in tumor samples contributes to accurately identifying potential treatment options for the personalized management of people with cancer.

GPS Cancer report include:

  • DNA and RNA alterations
  • Protein levels
  • FDA-approved therapies with potential clinical benefit
  • Therapies to which the tumor may be resistant
  • Active clinical trials of therapies that may have clinical benefit